MEGAN BRADSHAW: Open Payments
NPI 1376901405 · GREENFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,370 in 167 payments from 20 companies in 2025. Trend: 2023 $2,638 · 2024 $2,579 · 2025 $3,370
Food & beverage: $3,370
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $545 |
| Verona Pharma, Inc. | 20 | $444 |
| GENZYME CORPORATION | 20 | $364 |
| GlaxoSmithKline, LLC. | 24 | $311 |
| Regeneron Healthcare Solutions, Inc. | 12 | $302 |
| Grifols USA, LLC | 11 | $280 |
| Baxter Healthcare | 10 | $230 |
| Viatris Specialty LLC | 18 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
Products named: DUPIXENT, Ohtuvayre, Prolastin-C Liquid, Hillrom - Monarch Airway Clearance System, YUPELRI, GLASSIA, NUCALA, BREZTRI.
Industry payments across IN — which companies pay providers there.
